Centre Hospitalier Universitaire Mohamed VI

Marrakesh 40000

0 studies enrolling now · 2 studies all time

What they study most

Esophageal Squamous Cell Carcinoma, Triple Negative Breast Neoplasms

Studies at this site

• A Study of Atezolizumab With or Without Tiragolumab in Participants With Unresectable Esophageal Squamous Cell Carcinoma Whose Cancers Have Not Progressed Following Definitive Concurrent Chemoradiotherapy — Running, not enrolling
• A Study of the Efficacy and Safety of Atezolizumab Plus Chemotherapy for Patients With Early Relapsing Recurrent Triple-Negative Breast Cancer — Completed